Securities code: 300981 securities abbreviation: Zhonghong Pulin Medical Products Co.Ltd(300981) Announcement No.: 2022-005 Zhonghong Pulin Medical Products Co.Ltd(300981)
Announcement on using its own idle funds to invest in low-risk financial products
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Zhonghong Pulin Medical Products Co.Ltd(300981) (hereinafter referred to as “the company”) intends to use its own idle funds of no more than RMB 4 billion to purchase financial products with high safety, good liquidity and controllable risk under the condition of ensuring the capital demand for normal production and operation, which will be effective within one year from the date of deliberation and approval by the general meeting of shareholders. The details are as follows:
1、 Financial products
In order to improve the efficiency of capital use, on the premise of ensuring the company’s daily capital demand and capital safety, combined with the actual operation situation, it is planned to use its own funds to buy financial products, improve the company’s investment income and seek better investment return for the company and shareholders.
1. Varieties of financial products: in order to control risks, the varieties invested by the company are financial products with high safety, good liquidity and controllable risks, including the purchase of financial products issued by commercial banks, trusts and other financial institutions. On the premise of controllable risks, it can improve the use efficiency of the company’s own funds and increase the company’s income. The company has no affiliated relationship with the financial institutions providing financial products, does not involve affiliated transactions, and does not constitute a major asset reorganization. The above products determined by the company to invest do not belong to the scope of venture capital specified in the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 2 – standardized operation of companies listed on GEM.
2. Purchase amount and fund source: the amount of financial products purchased by the company with its own funds shall not exceed 4 billion yuan, which can be used in a rolling and recycling manner.
3. Investment term: the investment is valid within one year from the date of deliberation and approval by the general meeting of shareholders (calculated based on the time point of purchasing financial products). Within the term of validity, the company will purchase financial products according to different term combinations according to the fund use plan. The investment term of a single financial product shall not exceed 12 months.
4. Implementation method: authorize the chairman, general manager or their authorized person to exercise relevant decision-making power within the limit and sign relevant legal documents. The specific investment activities are organized and implemented by the finance department.
2、 Impact on the company
1. The company’s use of its own funds to purchase financial products with high safety, good liquidity and controllable risk is implemented under the guarantee of the company’s normal operating capital needs, which will not affect the needs of the company’s daily capital turnover and the normal development of the company’s main business.
2. By purchasing financial products with high security, good liquidity and controllable risk, we can increase the company’s income and seek a better return on investment for the company and shareholders.
3、 Investment risk and risk control
1. Investment risk
(1) The financial products to be invested by the company belong to risk controllable investment varieties, but the financial market is affected by many factors such as macro-economy. This investment does not rule out the adverse impact due to market fluctuations.
(2) The company will carry out timely and appropriate implementation according to the economic situation and changes in the financial market, and the actual income obtained by purchasing financial products is unpredictable.
(3) The investment income of financial products is affected by factors such as the relationship between supply and demand in the financial market and the change of interest rate market, which has a certain degree of uncertainty.
2. Investment risk control measures
(1) The company will strictly abide by the principle of prudent investment, choose investment varieties with controllable risks, and will not use funds directly or indirectly for securities investment.
(2) The Finance Department of the company will timely analyze and track the investment direction of financial products and the progress of the project. If it is found that there are risk factors that may affect the safety of the company’s funds, it will take corresponding measures in time to control the investment risk. (3) The board of supervisors and independent directors of the company have the right to supervise and inspect the use of funds, and can hire professional institutions to audit when necessary.
3. According to the relevant regulations of Shenzhen Stock Exchange, the company will disclose the purchase of financial products and the corresponding profit and loss during the reporting period in the regular report.
4、 Review procedure
1. Opinions of the board of directors
On February 23, 2022, the seventh meeting of the third board of directors of the company deliberated and approved the proposal on using its own idle funds to invest in low-risk financial products, and agreed that the company would use its own funds of no more than RMB 4 billion to purchase financial products with high safety, good liquidity and controllable risk on the premise of ensuring its normal operation and capital safety, It shall be valid for one year from the date of deliberation and approval by the general meeting of shareholders. Within the above limit, the funds can be used in rolling and recycling; At the same time, the general meeting of shareholders is requested to authorize the chairman, general manager or their authorized persons to exercise relevant decision-making power within the limit and sign relevant legal documents. This proposal still needs to be submitted to the general meeting of shareholders for deliberation.
2. Opinions of independent directors
The independent directors of the company expressed their independent opinions after reviewing the matters related to the company’s use of its own funds to purchase financial products. The specific contents are as follows:
On the premise of ensuring normal operation and capital safety, the company uses its own funds to purchase financial products, which is conducive to improving the use efficiency of the company’s funds and increasing investment income, which is in line with the interests of the company and all shareholders. The decision-making procedures for purchasing wealth management products with self owned funds this time comply with the provisions of the Shenzhen Stock Exchange gem stock listing rules (revised in 2022), Shenzhen Stock Exchange listed companies self regulatory guidance No. 2 – standardized operation of GEM listed companies, and the decision-making procedures are legal and compliant. All independent directors agreed to the proposal that the company use its own idle funds to invest in low-risk financial products, and agreed to submit it to the general meeting of shareholders for deliberation. 3. Opinions of the board of supervisors
On February 23, 2022, the sixth meeting of the third board of supervisors deliberated and adopted the proposal on using its own idle funds to invest in low-risk financial products. The board of supervisors held that the company’s use of its own idle funds to invest in low-risk financial products is conducive to improving the use efficiency of its own funds and obtaining certain investment income, Seek better return on investment for the company and shareholders. The use of its own idle funds to invest in low-risk financial products will not affect the company’s normal capital turnover and the development of normal production and operation activities, there is no damage to the interests of the company and shareholders, and the approval procedures comply with the relevant provisions of laws and regulations and the articles of association. The board of supervisors agrees with the proposal, which needs to be submitted to the general meeting of shareholders for deliberation and approval.
4. Opinions of the sponsor
The company’s sponsor Haitong Securities Company Limited(600837) conducted a special verification on matters related to the company’s use of its own idle funds to invest in low-risk financial products, and the special verification opinion issued is that: Zhonghong Pulin Medical Products Co.Ltd(300981) the purchase of financial products with its own funds has been reviewed and approved by the company’s board of directors, and the independent directors and the board of supervisors have expressed their consent, The matter can only be implemented after being submitted to the general meeting of shareholders for deliberation and approval. The decision-making procedures are legal and compliant, and comply with the provisions of relevant laws and regulations such as the Shenzhen Stock Exchange gem stock listing rules (revised in 2022), Shenzhen Stock Exchange listed companies self regulatory guidelines No. 2 – standardized operation of GEM listed companies. The company uses its own idle funds to purchase financial products with high safety, good liquidity and controllable risk, which is conducive to improving the efficiency of fund use, increasing the company’s income and seeking more investment returns for the company’s investors. To sum up, Haitong Securities Company Limited(600837) agrees that the company uses its own idle funds to invest in low-risk financial products.
5、 Documents for future reference
1. Resolutions of the seventh meeting of the third board of directors of the company;
2. Resolutions of the sixth meeting of the third board of supervisors of the company;
3. Independent opinions of the company’s independent directors on matters related to the seventh meeting of the third board of directors;
4. Haitong Securities Company Limited(600837) verification opinions on Zhonghong Pulin Medical Products Co.Ltd(300981) using its own idle funds to invest in low-risk financial products.
It is hereby announced.
Zhonghong Pulin Medical Products Co.Ltd(300981) board of directors February 23, 2002
